Cyclosporine A Promotes Bone Remodeling in LPS-Related Inflammation via Inhibiting ROS/ERK Signaling: Studies In Vivo and In Vitro

Cyclosporine A Promotes Bone Remodeling in LPS-Related Inflammation via Inhibiting ROS/ERK Signaling: Studies In Vivo and In Vitro

In some inflammatory diseases of bone, osteogenesis and osteoclasis are uncoupled and the balance is usually tipped resulting in bone destruction. The underlying mechanism of osteogenic dysfunction in inflammation still needs further study. This study is aimed at investigating the effects of cyclosp...

Full description

Bibliographic Details
Main Authors:	Yuwei Zhao, Jing Gao, Yarong Zhang, Xueqi Gan, Haiyang Yu
Format:	Article
Language:	English
Published:	Hindawi Limited 2021-01-01
Series:	Oxidative Medicine and Cellular Longevity
Online Access:	http://dx.doi.org/10.1155/2021/8836599

Similar Items

Cyclosporin a inhibits rotavirus replication and restores interferon-beta signaling pathway in vitro and in vivo.
by: Zigang Shen, et al.
Published: (2013-01-01)

GLP-2 Suppresses LPS-Induced Inflammation in Macrophages by Inhibiting ERK Phosphorylation and NF-κB Activation
by: Shanshan Xie, et al.
Published: (2014-08-01)

Dual Effect of Soloxolone Methyl on LPS-Induced Inflammation In Vitro and In Vivo
by: Andrey V. Markov, et al.
Published: (2020-10-01)

Cyclosporine A inhibits MRTF‐SRF signaling through Na+/K+ ATPase inhibition and actin remodeling
by: Bastien Burat, et al.
Published: (2019-09-01)

The anti-inflammation of erinacine A on LPS-induced Parkinson’s disease in vivo and in vitro
by: Jing-Ya Hsu, et al.
Published: (2016)

Loss of chemerin triggers bone remodeling in vivo and in vitro
by: Long Han, et al.
Published: (2021-11-01)

BRF1 ameliorates LPS-induced inflammation through autophagy crosstalking with MAPK/ERK signaling
by: Weiwei Xie, et al.
Published: (2018-09-01)

LPS-Induced G-CSF Expression in Macrophages Is Mediated by ERK2, but Not ERK1.
by: Shwu-Fen Chang, et al.
Published: (2015-01-01)

Deubiquitinase Inhibitor b-AP15 Attenuated LPS-Induced Inflammation via Inhibiting ERK1/2, JNK, and NF-Kappa B
by: Fangcheng Zhang, et al.
Published: (2020-04-01)

LPS aggravates lung inflammation induced by RSV by promoting the ERK-MMP-12 signaling pathway in mice
by: Shenglin Chen, et al.
Published: (2020-07-01)

Inhibition of HMGB1 Promotes Osseointegration under Hyperglycemic Condition through Improvement of BMSC Dysfunction
by: Beilei Liu, et al.
Published: (2019-01-01)

Deacetyl Ganoderic Acid F Inhibits LPS-Induced Neural Inflammation via NF-κB Pathway Both In Vitro and In Vivo
by: Feiya Sheng, et al.
Published: (2019-12-01)

Inhibition of LPS-Induced Cellular Inflammation by Phytotoxin Aristolochic Acid
by: I-Tzu, et al.
Published: (2008)

NOX1 Inhibition Attenuates Kidney Ischemia-Reperfusion Injury via Inhibition of ROS-Mediated ERK Signaling
by: Hee-Yeon Jung, et al.
Published: (2020-09-01)

GLP-2 Attenuates LPS-Induced Inflammation in BV-2 Cells by Inhibiting ERK1/2, JNK1/2 and NF-κB Signaling Pathways
by: Nan Li, et al.
Published: (2016-02-01)

A comparison of the immunosuppressive efficacy of Cyclosporine A (CsA) and Cyclosporine G (CsG) in vitro and in vivo
by: Rayat, Gina Ranile
Published: (2013)

A comparison of the immunosuppressive efficacy of Cyclosporine A (CsA) and Cyclosporine G (CsG) in vitro and in vivo
by: Rayat, Gina Ranile
Published: (2013)

AS-703026 Inhibits LPS-Induced TNFα Production through MEK/ERK Dependent and Independent Mechanisms.
by: Ping Li, et al.
Published: (2015-01-01)

Effects of Anti-IL-17 on Inflammation, Remodeling, and Oxidative Stress in an Experimental Model of Asthma Exacerbated by LPS
by: Leandro do Nascimento Camargo, et al.
Published: (2018-01-01)

Astragalus Polysaccharide Suppresses Skeletal Muscle Myostatin Expression in Diabetes: Involvement of ROS-ERK and NF-κB Pathways
by: Min Liu, et al.
Published: (2013-01-01)

Quantifying the roles of stimulated osteocytes and inflammation in bone remodeling
by: George, Estee L.
Published: (2019)

Cyclosporine A sensitizes lung cancer cells to crizotinib through inhibition of the Ca2+/calcineurin/Erk pathwayResearch in context
by: Zhen Liu, et al.
Published: (2019-04-01)

Neohesperidin inhibits cardiac remodeling induced by Ang II in vivo and in vitro
by: Jingsi Zhang, et al.
Published: (2020-09-01)

SYPL1 Inhibits Apoptosis in Pancreatic Ductal Adenocarcinoma via Suppression of ROS-Induced ERK Activation
by: Yunda Song, et al.
Published: (2020-09-01)

Lipoxin A4 Attenuates Cell Invasion by Inhibiting ROS/ERK/MMP Pathway in Pancreatic Cancer
by: Liang Zong, et al.
Published: (2016-01-01)

GSH attenuates RANKL-induced osteoclast formation in vitro and LPS-induced bone loss in vivo
by: Bing Han, et al.
Published: (2020-08-01)

Monocrotaline Suppresses RANKL-Induced Osteoclastogenesis In Vitro and Prevents LPS-Induced Bone Loss In Vivo
by: Cheng-Ming Wei, et al.
Published: (2018-07-01)

Pantoprazole (PPZ) Inhibits RANKL-Induced Osteoclast Formation and Function In Vitro and Prevents Lipopolysaccharide- (LPS-) Induced Inflammatory Calvarial Bone Loss In Vivo
by: Yu-Xi Li, et al.
Published: (2020-01-01)

Scoparone Inhibits LPS-Simulated Inflammatory Response by Suppressing IRF3 and ERK in BV-2 Microglial Cells
by: Duk-Yeon Cho, et al.
Published: (2016-12-01)

Bone-targeted methotrexate–alendronate conjugate inhibits osteoclastogenesis in vitro and prevents bone loss and inflammation of collagen-induced arthritis in vivo
by: Zi’ang Xie, et al.
Published: (2018-01-01)

LPS Pretreatment Attenuates Cerebral Ischaemia/Reperfusion Injury by Inhibiting Inflammation and Apoptosis
by: Zhiquan Lv, et al.
Published: (2018-03-01)

Ultrasound May Suppress Tumor Growth, Inhibit Inflammation, and Establish Tolerogenesis by Remodeling Innatome via Pathways of ROS, Immune Checkpoints, Cytokines, and Trained Immunity/Tolerance
by: Qian Yang, et al.
Published: (2021-01-01)

T4 Phage Tail Adhesin Gp12 Counteracts LPS-induced Inflammation In Vivo
by: Paulina Miernikiewicz, et al.
Published: (2016-07-01)

Suppression of LPS-Induced Inflammation by Chalcone Flavokawain A through Activation of Nrf2/ARE-Mediated Antioxidant Genes and Inhibition of ROS/NFκB Signaling Pathways in Primary Splenocytes
by: Hsin-Ling Yang, et al.
Published: (2020-01-01)

Protective Effects of Evodiamine against LPS-Induced Acute Kidney Injury through Regulation of ROS-NF-κB-Mediated Inflammation
by: Yan Shi, et al.
Published: (2019-01-01)

Effects of Polymethoxyflavonoids on Bone Loss Induced by Estrogen Deficiency and by LPS-Dependent Inflammation in Mice
by: Shigeru Matsumoto, et al.
Published: (2018-01-01)

Roles of ERK2 in LPS-induced G-CSF expression in macrophage
by: Shih-Shan Lin, et al.
Published: (2012)

Effects of cytokine signaling inhibition on inflammation-driven tissue remodeling
by: Rebecca Bignold, et al.
Published: (2021-01-01)

Lycorine Attenuates Autophagy in Osteoclasts via an Axis of mROS/TRPML1/TFEB to Reduce LPS-Induced Bone Loss
by: Hyun-Jung Park, et al.
Published: (2019-01-01)

An Implanted Magnetic Microfluidic Pump for In Vivo Bone Remodeling Applications
by: Ziyu Chen, et al.
Published: (2020-03-01)